Suppr超能文献

微小RNA-137通过靶向类固醇受体共激活因子3抑制人非小细胞肺癌细胞的增殖。

miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.

作者信息

Chen Ruilin, Zhang Yongqing, Zhang Chengcheng, Wu Hua, Yang Shumei

机构信息

Department of Respiratory Medicine, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China.

出版信息

Oncol Lett. 2017 May;13(5):3905-3911. doi: 10.3892/ol.2017.5904. Epub 2017 Mar 24.

Abstract

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. The results of the present study demonstrate that high expression of microRNA (miR)-137 and low expression of steroid receptor coactivator-3 (SRC3) had a significant negative correlation in 40 NSCLC tissue samples. In addition, cell colony formation and proliferation was significantly reduced in miR-137-transfected A549 and NCI-H838 cells compared with scramble-transfected NSCLC cell lines. miR-137 was identified to induce G/S cell cycle arrest and dysregulate the mRNA expression of cell cycle-associated proteins (proliferating cell nuclear antigen, cyclin E, cyclin A1, cyclin A2 and p21) in NSCLC cells. Notably, miR-137 could significantly suppress SRC3 3' untranslated region (UTR) luciferase-reporter activity, an effect that was not detectable when the putative 3'-UTR target-site was mutated, further clarifying the molecular mechanisms underlying the role of miR-137 in NSCLC. In conclusion, the results of the present study suggest that miR-137 suppresses NSCLC cell proliferation by partially targeting SRC3.

摘要

非小细胞肺癌(NSCLC)是最常见的肺癌类型。本研究结果表明,在40例NSCLC组织样本中,微小RNA(miR)-137的高表达与类固醇受体辅激活因子3(SRC3)的低表达呈显著负相关。此外,与乱序转染的NSCLC细胞系相比,miR-137转染的A549和NCI-H838细胞的细胞集落形成和增殖明显减少。已确定miR-137可诱导NSCLC细胞发生G/S期细胞周期阻滞并使细胞周期相关蛋白(增殖细胞核抗原、细胞周期蛋白E、细胞周期蛋白A1、细胞周期蛋白A2和p21)的mRNA表达失调。值得注意的是,miR-137可显著抑制SRC3 3'非翻译区(UTR)荧光素酶报告基因活性,当假定的3'-UTR靶位点发生突变时,这种效应无法检测到,这进一步阐明了miR-137在NSCLC中作用的分子机制。总之,本研究结果表明,miR-137通过部分靶向SRC3抑制NSCLC细胞增殖。

相似文献

1
miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.
Oncol Lett. 2017 May;13(5):3905-3911. doi: 10.3892/ol.2017.5904. Epub 2017 Mar 24.
3
MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC.
Cell Physiol Biochem. 2018;46(2):654-663. doi: 10.1159/000488634. Epub 2018 Mar 28.
5
MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
FEBS Open Bio. 2019 Nov;9(11):1983-1993. doi: 10.1002/2211-5463.12738. Epub 2019 Oct 24.
6
MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 2016 May 10;35:76. doi: 10.1186/s13046-016-0357-4.
7
MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5546-5553. doi: 10.26355/eurrev_201809_15816.
8
MicroRNA-1304 suppresses human non-small cell lung cancer cell growth in vitro by targeting heme oxygenase-1.
Acta Pharmacol Sin. 2017 Jan;38(1):110-119. doi: 10.1038/aps.2016.92. Epub 2016 Sep 19.

引用本文的文献

1
miR-137: a potential therapeutic target for lung cancer.
Front Cell Dev Biol. 2024 Aug 23;12:1427724. doi: 10.3389/fcell.2024.1427724. eCollection 2024.
3
lncRNA DSCR8 mediates miR-137/Cdc42 to regulate gastric cancer cell proliferation, invasion, and cell cycle as a competitive endogenous RNA.
Mol Ther Oncolytics. 2021 May 29;22:468-482. doi: 10.1016/j.omto.2021.05.010. eCollection 2021 Sep 24.
5
HAS2-AS1 Acts as a Molecular Sponge for miR-137 and Promotes the Invasion and Migration of Glioma Cells by Targeting EZH2.
Cell Cycle. 2020 Nov;19(21):2826-2835. doi: 10.1080/15384101.2020.1826237. Epub 2020 Oct 16.
7
Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.
PeerJ. 2020 May 6;8:e9086. doi: 10.7717/peerj.9086. eCollection 2020.
8
10
Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.
Front Cell Dev Biol. 2019 Oct 1;7:221. doi: 10.3389/fcell.2019.00221. eCollection 2019.

本文引用的文献

1
MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.
Biochem Biophys Res Commun. 2015 Sep 11;465(1):125-30. doi: 10.1016/j.bbrc.2015.07.145. Epub 2015 Jul 30.
3
miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21 pathway.
Oncol Lett. 2015 Jun;9(6):2743-2749. doi: 10.3892/ol.2015.3068. Epub 2015 Mar 23.
4
microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.
Int J Biol Macromol. 2015 Mar;74:111-8. doi: 10.1016/j.ijbiomac.2014.12.002. Epub 2014 Dec 11.
5
MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells.
Tumour Biol. 2014 Jul;35(7):6955-60. doi: 10.1007/s13277-014-1933-x. Epub 2014 Apr 17.
6
MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation.
Biomed Pharmacother. 2014 Feb;68(1):7-12. doi: 10.1016/j.biopha.2013.12.002. Epub 2013 Dec 24.
7
miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin.
Hum Cell. 2014 Jul;27(3):95-102. doi: 10.1007/s13577-013-0085-4. Epub 2013 Nov 17.
10
Molecular regulation of stem cell quiescence.
Nat Rev Mol Cell Biol. 2013 Jun;14(6):329-40. doi: 10.1038/nrm3591.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验